Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Roux-en-Y Gastric Bypass (RYGB) Bariatric Surgery on System Pharmacology: Single-dose Cross-over Pharmacokinetic Study of Simvastatin and Carvedilol.

NCT04049786 is registered in ClinicalTrials.gov with Natalia Valadares de Moraes as lead sponsor.

NCT NCT04049786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Roux-en-Y Gastric Bypass (RYGB) Bariatric Surgery on System Pharmacology: Single-dose Cross-over Pharmacokinetic Study of Simvastatin and Carvedilol.
Lead sponsor
Natalia Valadares de Moraes
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2019
Completion date
August 31, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery, obesity, roux-en y gastric bypass